Search research articles
Contact Us
Filters
Showing results (341-350 of 457) with videos related to
Page
of 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2016
A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
Keith W Pratz, Michelle A Rudek, Ivana Gojo, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
Haematologica
|
July 28, 2011
Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia
Scott H Kaufmann, Judith E Karp, Mark R Litzow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 15, 2012
HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies
Minoo Battiwalla, Kristin Ellis, Peigang Li, et al.
Blood Cancer Journal
|
January 26, 2022
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
Rong He, Jonathan Chiou, Allison Chiou, et al.
Haematologica
|
June 20, 2024
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(<i>DEK::NUP214</i>): the Mayo Clinic experience
Clifford M Csizmar, Antoine N Saliba, Patricia T Greipp, et al.
JAMA
|
March 7, 2023
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant
Laura W Dillon, Gege Gui, Kristin M Page, et al.
Bone Marrow Transplantation
|
October 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Pranay S Hegde, Georgia Andrew, Gege Gui, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures
Kelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
JAMA Oncology
|
February 27, 2025
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial
Anand P Jillella, Sandra J Lee, Jessica K Altman, et al.
Page
of 46
Search research articles
Search
Showing results (341-350 of 457) with videos related to
Sort By:
Page
of 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2016
A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
Keith W Pratz, Michelle A Rudek, Ivana Gojo, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
Haematologica
|
July 28, 2011
Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia
Scott H Kaufmann, Judith E Karp, Mark R Litzow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 15, 2012
HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies
Minoo Battiwalla, Kristin Ellis, Peigang Li, et al.
Blood Cancer Journal
|
January 26, 2022
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
Rong He, Jonathan Chiou, Allison Chiou, et al.
Haematologica
|
June 20, 2024
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(<i>DEK::NUP214</i>): the Mayo Clinic experience
Clifford M Csizmar, Antoine N Saliba, Patricia T Greipp, et al.
JAMA
|
March 7, 2023
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant
Laura W Dillon, Gege Gui, Kristin M Page, et al.
Bone Marrow Transplantation
|
October 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Pranay S Hegde, Georgia Andrew, Gege Gui, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures
Kelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
JAMA Oncology
|
February 27, 2025
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial
Anand P Jillella, Sandra J Lee, Jessica K Altman, et al.
Page
of 46